Califia Pharma, Inc.

Califia is developing novel drugs active against drug resistant cancers unresponsive to current therapies, while displaying minimal toxicity in humans.

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded September 2015
  • Employees 2
  • Incorporation Type C-corp
  • Website n.a.

Company Summary

Califia is developing drugs for treating TCR-deficient solid tumors (ovarian, endometrial, prostate, liver, etc). Recent clinical trials of the 1st gen TCR drug validates our approach. Califia is poised to improve on success with a 2nd gen drug (CAP-0121) displaying superior PK/stability/efficacy that is combined with a molecular-based companion diagnostic to identify patients whose cancers are TCR deficient.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free